Gene expression profile of epithelial-mesenchymal transition mediators in papillary thyroid cancer
- 1 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 72 (2), 452-461
- https://doi.org/10.1007/s12020-020-02466-3
Abstract
Purpose Platelet derived growth receptor alpha (PDGFRA) promotes the epithelial-mesenchymal transition (EMT) in thyroid follicular cells and is linked to lymphatic metastases in papillary thyroid cancer (PTC). We probed the regulatory network of genes linked to PDGFRA and EMT, comparing matched patient primary tumor and metastatic specimens, as well as engineered cell lines and ex vivo primary cultures with and without PDGFRA. Methods Freshly isolated thyroid tumors with or without metastases, with matching neighboring benign or normal tissue, was isolated for comparative transcriptional analysis using a TaqMan Low Density array (TLDA) assay with genes representing important markers of EMT, cellular adhesion, apoptosis, differentiation, senescence, and signal transduction pathways in thyroid cancer. Transfected primary cultures and immortalized cell lines were also analyzed with respect to PDGFRA expression and cell phenotype. Results We reveal the consistent upregulation of serine protease DPP4 and structural protein SPP1 with the progression of PTC to metastatic disease, as well as with PDGFRA expression. Conversely, epithelial integrity gene TFF3 and transcription factor SOX10 were strongly down-regulated. This gene network also includes important mediators of EMT including DSG1, MMP3, MMP9, and BECN. We observed similar genomic changes in ex vivo normal thyroid cells transfected with PDGFRA that also exhibited a partially dedifferentiated phenotype. In particular, we observed lamellopodia with induction of PDGFRA and illustrate that DPP4 and SPP1 were upregulated in this process, with decreased TFF3 and SOX10 as seen in tissue specimens. PDGFRA did decrease nuclear protein levels of differentiation factor TTF1, but not the transcription of TTF1 and PAX8. Conclusions We demonstrate that PDGFRA activates EMT pathways and decreases expression of genes favoring epithelial integrity, pushing follicular cells toward a dedifferentiated phenotype. SPP1 and DPP4, previously linked with adverse outcomes in thyroid cancer, appear to be regulated by PDGFRA. PDGFRA expression promotes metastatic disease through multiple EMT levers that favor formation of an invasive phenotype and increased metalloproteinase expression.This publication has 43 references indexed in Scilit:
- The Roles of the Epithelial-Mesenchymal Transition Marker PRRX1 and miR-146b-5p in Papillary Thyroid Carcinoma ProgressionThe American Journal of Pathology, 2014
- Whole-Transcriptome Profiling of Thyroid Nodules Identifies Expression-Based Signatures for Accurate Thyroid Cancer DiagnosisJournal of Clinical Endocrinology & Metabolism, 2013
- The protective effect of trefoil factor 3 on the intestinal tight junction barrier is mediated by toll-like receptor 2 via a PI3K/Akt dependent mechanismBiochemical and Biophysical Research Communications, 2013
- Invading one step at a time: the role of invadopodia in tumor metastasisOncogene, 2013
- Thyroid cancer cell lines: an overviewFrontiers in Endocrinology, 2012
- STT3A , C1orf24 , TFF3 : Putative Markers for Characterization of Follicular Thyroid Neoplasms From Fine-Needle AspiratesThe Laryngoscope, 2011
- Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodulesThyroid Research, 2011
- Gene Expression Profiling of Papillary Thyroid Carcinoma Identifies Transcripts Correlated with BRAF Mutational Status and Lymph Node MetastasisClinical Cancer Research, 2008
- Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasmsLaboratory Investigation, 2008
- Immunohistochemical analysis of thyroid‐specific transcription factors in thyroid tumorsPathology International, 2006